Abstract

Background: Patient-reported outcome (PRO) measures historically used in inflammatory bowel disease have been considered inadequate to support future drug labelling claims by regulatory agencies.

Tags

Crohn's Disease, Health Impact Assessment, Outcome Assessment, Pathology, Psychology, Psychometrics, Ulcerative Colitis

Read More